Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics

The purpose of the studies included in this thesis is to develop an effective an efficient method to study the proteome using separation and detection of peptides, when only a limited amount of sample, 10 micrograms of total protein or less, is available. The analysis will be applied to multiple mye...

Full description

Bibliographic Details
Main Author: Izumi, Victoria
Format: Others
Published: Scholar Commons 2018
Subjects:
Online Access:https://scholarcommons.usf.edu/etd/7526
https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=8723&context=etd
id ndltd-USF-oai-scholarcommons.usf.edu-etd-8723
record_format oai_dc
spelling ndltd-USF-oai-scholarcommons.usf.edu-etd-87232019-10-04T05:06:14Z Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics Izumi, Victoria The purpose of the studies included in this thesis is to develop an effective an efficient method to study the proteome using separation and detection of peptides, when only a limited amount of sample, 10 micrograms of total protein or less, is available. The analysis will be applied to multiple myeloma cancer cells using ultra high-performance liquid chromatography-mass spectrometry for expression proteomics to illustrate utility. To detect low abundance peptides in a complex proteome, we use different strategies, including basic pH reversed-phase liquid chromatography (bRPLC), mass-to-charge fractionation in the mass spectrometer, and various liquid chromatography gradients to increase peptide separation to improve opportunities for detection and quantification. The different methods are optimized and compared by the number of peptides detected. Step-wise elution of bRP spin columns proved to yield more than 36,000 peptides using only 10 μg of protein. Mass-to-charge (m/z) fractionation was tested in mass analyzer Q-Exactive Plus (Thermo Scientific). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) of an unfractionated sample was analyzed 4 times at different mass ranges, each mass range width of 150 m/z, resulting from 4 spectra combined, 31,732 peptides representing 3,967 proteins. Showingcomparable results to those form high pH reversed phase fractionation spin columns 5 fractions. Establishing a benchmark where the LC-MS/MS analysis of 600 μg of 10plex TMT-labeled peptides fractionated with bRPLC into 24 fractions yielded over 74,000 peptides from 7,700 proteins, we compared those results with analysis of 10 μg of total TMT-labeled peptides fractionated by bRP spin columns into 5 fractions, which produced 14,019 peptides from 3,538 proteins. These experiments were used to relatively quantify protein expression in naïve and drug resistant multiple myeloma cells lines as an example application in cancer research. 2018-11-01T07:00:00Z text application/pdf https://scholarcommons.usf.edu/etd/7526 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=8723&context=etd Graduate Theses and Dissertations Scholar Commons LC-MS/MS TMT10plex High pH Reversed Phase Concatenation Chemistry
collection NDLTD
format Others
sources NDLTD
topic LC-MS/MS
TMT10plex
High pH Reversed Phase
Concatenation
Chemistry
spellingShingle LC-MS/MS
TMT10plex
High pH Reversed Phase
Concatenation
Chemistry
Izumi, Victoria
Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
description The purpose of the studies included in this thesis is to develop an effective an efficient method to study the proteome using separation and detection of peptides, when only a limited amount of sample, 10 micrograms of total protein or less, is available. The analysis will be applied to multiple myeloma cancer cells using ultra high-performance liquid chromatography-mass spectrometry for expression proteomics to illustrate utility. To detect low abundance peptides in a complex proteome, we use different strategies, including basic pH reversed-phase liquid chromatography (bRPLC), mass-to-charge fractionation in the mass spectrometer, and various liquid chromatography gradients to increase peptide separation to improve opportunities for detection and quantification. The different methods are optimized and compared by the number of peptides detected. Step-wise elution of bRP spin columns proved to yield more than 36,000 peptides using only 10 μg of protein. Mass-to-charge (m/z) fractionation was tested in mass analyzer Q-Exactive Plus (Thermo Scientific). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) of an unfractionated sample was analyzed 4 times at different mass ranges, each mass range width of 150 m/z, resulting from 4 spectra combined, 31,732 peptides representing 3,967 proteins. Showingcomparable results to those form high pH reversed phase fractionation spin columns 5 fractions. Establishing a benchmark where the LC-MS/MS analysis of 600 μg of 10plex TMT-labeled peptides fractionated with bRPLC into 24 fractions yielded over 74,000 peptides from 7,700 proteins, we compared those results with analysis of 10 μg of total TMT-labeled peptides fractionated by bRP spin columns into 5 fractions, which produced 14,019 peptides from 3,538 proteins. These experiments were used to relatively quantify protein expression in naïve and drug resistant multiple myeloma cells lines as an example application in cancer research.
author Izumi, Victoria
author_facet Izumi, Victoria
author_sort Izumi, Victoria
title Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
title_short Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
title_full Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
title_fullStr Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
title_full_unstemmed Optimizing Peptide Fractionation to Maximize Content in Cancer Proteomics
title_sort optimizing peptide fractionation to maximize content in cancer proteomics
publisher Scholar Commons
publishDate 2018
url https://scholarcommons.usf.edu/etd/7526
https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=8723&context=etd
work_keys_str_mv AT izumivictoria optimizingpeptidefractionationtomaximizecontentincancerproteomics
_version_ 1719260349973135360